Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.

When Dr. Patel meets with patients and their families, he walks them step-by-step through the treatment plan and ensures that they receive the most-effective surgery, when that is the best approach for the patient.

Dr. Sclafani, who practices at Memorial Sloan-Kettering Commack, wants newly diagnosed patients to leave her office with hope and with a plan of action for treating the cancer.

The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan-Kettering researchers.

Our Office of Diversity Programs offers information and resources about clinical care, research, and training focused on reducing cancer health disparities in medically underserved populations.

Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.